1. Introduction
Fungal infections cause serious diseases that greatly impact human and animal health since they are by microorganisms (fungi) similar to the metabolism and cellular activity of host cells. Therefore, it is difficult to diagnose and treat them. It is also challenging to identify fungal species (spp.) ( 1 ). Candida is a normal flora of the mucous membrane of the upper respiratory tract. It can also become a pathogen yeast, which then invades the mucous membrane and causes candidiasis (opportunistic infection) in the immunosuppressed system ( 2 ). Invasive fungal infections have noticeably increased in humans in the form of superficial and systemic diseases ( 3 ). Candida intermedia (C. intermedia) is a Candida that is rarely found as a microflora on the surface of the cheese and in humans’ oropharyngeal cavity; therefore, it has seldom been associated with human diseases ( 4 ). This organism has been reported in a case series of fungemia; however, there is still a lack of detailed clinical and microbiological information ( 5 ). Trichosporon spp. are naturally found in water and soil; they may also be a part of normal human flora and colonize the skin, respiratory tract, gastrointestinal tracts, vagina, as well as urine ( 6 ). Trichosporon asahii (T. asahii) is a systemic fungal infection found in hosts with immunosuppressed, immunocompromised, and immunodeficient systems. It has been identified as a cause of fatal invasive fungal infection in patients with severe anthropogenic cancer, as well as hematopoietic cell transplant recipients. There are a few reports of T. asahii infection in patients with single organ transplants, human immunodeficiency virus infection, burns, catheter-related infections, peritoneal dialysis, and prosthetic heart valves ( 7 ). Based on the immune efficiency of the host, clinical signs vary from localized skin lesions in the immune-competent hosts to disseminated systemic infections in immunocompromised patients ( 8 ). Culture characteristics of T. asahii resemble the Candida spp.; however, it does not form the germ tube as Candida albicans do ( 9 ). Due to the importance of T. asahii in patients with immunodeficiency and underlying diseases, this study was performed to isolate and identify T. asahii in diabetic patients in Iraq.
2. Materials and Methods
2.1. Sampling
Samples were collected from the depth of diabetic foot patients’ wounds (taking aseptic precautions) after the debridement. These samples were collected from Al-Sadder Medical City in Al-Najaf province, Iraq, from November 2020 to January 2021. All of the above samples were transferred to the Laboratory of Advanced Mycology in the Faculty of Sciences, University of Kufa, Kufa, Iraq.
2.2. Isolation in Culture Medium
Samples were inoculated into Sabouraud Dextrose Agar (SDA) and incubated at 30°C to 35°C for 5 to 7 days for the growth of fungal microorganisms. The colonies were identified based on their macroscopic and microscopic features. Yeast samples were cultured in the CHROMagar for the isolation and identification of Candida spp.
2.3. Molecular Identification and Sequencing
Total DNA was extracted from the culture broth, and 1.5 ml of culture broth was pipetted into Eppendorf tubes. Afterward, it was centrifuged at 4.300×g for 5 min, and the supernatant was discarded. Subsequently, 200 ul of TE buffer was added, vortexes well were boiled for 10 min, and then put on ice immediately for 1 min. This was centrifuged again at 6.700×g for 10 min, and the supernatant was collected, which was used as the DNA template.
The Polymerase Chain Reaction (PCR) assay was performed to amplify the internal transcribed spacer 1 (ITS1) and the Internal transcribed spacer 4 (ITS4) sequences for the identification of yeasts. In this study, the primer pair was ITS1-F (5'-TCCGTAGGTGAACCTGCGG-3') and ITS4-R (5'-TCCTCCGCTTATTGATATGC-3') ( 10 ). The PCR mixture was prepared as 5 µl of master mix, which was supplied to be followed by 5 µl template DNA extract, 2.5 µl of 10 pmol/µl reveres primer, and 2.5 µl of 10 pmol/µl forward primer. The volume was then completed to 20 µl with deionized distilled water, and the tube was mixed with the vortex. The PCR amplification system was utilized as follows: initial denaturation for 4 min at 94°C, 30 sec at 94°C, 30 sec at 56°C, 30 sec 72°C, 35 cycles, and 7 min at 72°C. The PCR products were then separated by electrophoresis on 1.3% (w/v) agarose gel and stained in ethidium bromide. Afterward, the DNA sequencing of the PCR products of fungal spp. was sent to the Macrogen Lab in the USA to receive the data of sequences for every fungal spp. Until the sequencing reaction, the PCR product was purified with the Promega kit (Madison, USA), according to the instructions given by the company. Afterward, it was subjected to the sequencing results for a multi-alignment setup on Bio Edit software. The PCR product was then sequenced by the Sanger method.
3. Results and Discussion
Microscopic examination is a preliminary test to diagnose candidiasis. In the present study, the microscopic examination was performed at the Laboratory of Advanced Mycology in the Faculty of Sciences, University of Kufa, Kufa, Iraq. Each sample was stained with Lacto-phenol cotton blue, and a direct microscopic examination was conducted for the identification of the chlamydospores and pseudohyphae C. intermedia (Figure 1).
The genus T. asahii is characterized by the ability to form arthroconidia, blastoconidia, hyphae, and pseudohyphae ( 11 ).
All collected samples were cultured on the SDA. Colonies of C. intermedia were smooth, butyrous, and wrinkled margin, while the isolated T. asahii was characterized by smooth, flat, and creamy colonies; however, both grew at 30°C to 35°C for 5 to 7 days ( 12 ) (Figure 2).
This study showed that using CHROMagar, as a differential agar, was suitable for the diagnosis of Candida spp., especially C. intermedia. The colonies of C. intermedia appeared onion color with wrinkled peripheral. This finding is in disagreement with the results of a study conducted by Agrawal, Bhagwat ( 12 ), which detected the colonies of C. intermedia as dark purple and those of T. asahii as light blue on the CHROMagar. However, the findings are consistent with the results obtained in another study by Lu, Lo ( 13 ), in which the same characteristics were found with regards to T. asahii colonies that appeared on CHROMagar; thereby disagreeing with the results of Agrawal, Bhagwat ( 12 ), in which it appeared pale lavender with a white rim of T. asahii on CHROMagar (Figure 3).
Chromogenic media are effective and rapid ways of testing for the diagnosis of Candida spp., especially C. intermedia at the spp. level regarding the resulting color after inoculation. Compared to other culture traditional methods, the medium greatly facilitates the detection of specimens containing mixtures of yeast spp. due to changes in color produced by the reactions of species-specific enzymes with a proprietary chromogenic substrate. All of the tested yeast isolates grew on CHROMagar Candida after 5 to 7 days of incubation at 30°C to 35°C, the majority of the tested yeasts had grown well, as specified in the manufacturer’s instructions ( 14 ).
The results showed that the molecular sizes in the ITS region were different in the detected yeast spp. The PCR products of isolates are shown in figure 4 and table 1. The primer pair was used for the samples (i.e., ITS1-ITS4) and targeted the ITS regions. The identification of C. intermedia was performed according to the methodology proposed by Bellemain, Carlsen ( 15 ).
Yeast identifies | Molecular weight (bp) |
---|---|
Trichosporon asahii | 535–537 |
Candida intermedia | 384-388 |
The six samples of the amplified PCR products (forward and reverse strands) were sent to the Macrogen Lab in the USA and were compared with reference global sequences in the national center for biotechnology information (NCBI) Gene Bank.
Strain sequencing (L3, L29, L31, L33, L34, and L35) and alignment with the NCBI database were performed using BLAST software. Multi-sequence alignment was conducted by Bio Edit software and immediately submitted to the NCBI through sequin software.
The L3-LF strain was found to be the nearest neighbor to T. asahii strain KTSMBNL-12 with an identity of 99.21%, which was isolated from poultry feces. The L3-LR strain was identified as the nearest neighbor to T. asahii strain KY495727.1 with an identity of 98.97%. The L29-LF strain was found to be the nearest neighbor to C. intermedia strain KY495735.1 with an identity of 98.87%, and the L29-LR strain was identified as the nearest neighbor to C. intermedia strain KY102157.1, which was isolated from a human with an identity of 99.70%. The L31-LF strain was the closest neighbor to C. intermedia strain KM246246.1 with an identity of 99.44%. The L31-LR, as well as L33-LR strain, was found to be the nearest neighbors to C. intermedia strain DQ657830.1 with an identity of 99.58% and 98.87%, respectively. The L33-LF strain was the closest neighbor to C. intermedia strain MT38726.1 with an identity of 99.71%. The L34-LF strain was found to be the nearest neighbor to C. intermedia strain MT138722.1 with an identity of 98.87%. The L34-LR strain was found to be the nearest neighbor to C. intermedia strain DQ657830.1 with an identity of 98.88%. The L35-LF, as well as L35-LR strain, were identified as the nearest neighbors to C. intermedia strains DQ6828337.1 and DQ657830.1 with an identity of 99.15% and 98.60%, respectively.
The taxonomic predicted to discriminate yeast spp. at 98.41% for the ITS and 99.51% for the large subunit ribosomal (LSU) gene, respectively. It also showed that the strains of yeast spp. differ by less than 1% in the ITS and LSU regions ( 16 ). Accordingly, they are considered a suitable marker in the identification and diagnosis of yeasts. Due to the importance of the growth of these yeasts in patients with immunodeficiency and underlying diseases, such as diabetes, it is essential to identify and diagnose them to take appropriate treatment measures. In addition to traditional methods and culture media, the use of gene markers is also recommended in identifying wound contaminants.
Authors' Contribution
Study concept and design: A. Y. K.
Acquisition of data: M. M. A.
Analysis and interpretation of data: M. M. A.
Drafting of the manuscript: A. Y. K.
Critical revision of the manuscript for important intellectual content: M. M. A.
Statistical analysis: A. Y. K.
Administrative, technical, and material support: M. M. A.
Ethics
This study was approved by the Ethics Committee of Sciences at the University of Kufa, Kufa, Iraq, and all participants were requested to sign a consent form before participating in this study.
Conflict of Interest
The authors declare that they have no conflict of interest.
References
- Carmona EM, Limper AH. Overview of treatment approaches for fungal infections. Clin Chest Med. 2017; 38(3):393-402.
- Mohandas V, Ballal M. Distribution of Candida species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in southern India. J Glob Infect Dis. 2011; 3(1):4.
- Nerurkar A, Solanky P, Chavda N, Baria H, Desai B. Isolation of Candida Species in clinical specimens and its virulence factor: The biofilm. Int J Med Sci Public Health. 2012; 1(2):97-100.
- Melo N, Taguchi H, Jorge J, Pedro R, Almeida O, Fukushima K, et al. Oral Candida flora from Brazilian human immunodeficiency virus-infected patients in the highly active antiretroviral therapy era. Mem Inst Oswaldo Cruz. 2004; 99(4):425-31.
- Chen T-C, Chen Y-H, Tsai J-J, Peng C-F, Lu P-L, Chang K, et al. Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan. J Microbiol Immunol Infect. 2005; 38(3):200-10.
- Colombo AL, Padovan ACB, Chaves GM. Current knowledge of Trichosporon spp. and Trichosporonosis. Clin Microbiol Rev. 2011; 24(4):682-700.
- Devi KM, Mate PH, Singh LN, Devi KR, Devi KS. Disseminated infection with Trichosporon asahii in an immunocompetent patient: a rare case report. J Med Soc. 2015; 29(3):174.
- Go S-E, Lee K-J, Kim Y, Choi J-K, Kim Y-J, Lee D-G. Catheter-related Trichosporon asahii bloodstream infection in a neutropenic patient with myelodysplastic syndrome. Infect Chemother. 2018; 50(2):138-43.
- Ebright JR, Fairfax MR, Vazquez JA. Trichosporon asahii, a non-Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin Infect Dis. 2001; 33(5):e28-e30.
- White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. a guide to methods and application: PCR protocols.
- El-Mashad N, Mahmoud MT, allah El-Shewehy H. Trichosporon identification methods for isolates obtained from different clinical specimens. Afr J Microbiol Res. 2011; 5(9):1097-101.
- Agrawal V, Bhagwat A, Vishalakshi V, Gode V, Sawant C. Exploring the potential of chromogenic medium for the identification of medically important yeast species other than Candida. Int J Pharm Pharm Sci. 2014; 6(3):291-4.
- Lu J-J, Lo H-J, Lee C-H, Chen M-J, Lin C-C, Chen Y-Z, et al. The use of MALDI-TOF mass spectrometry to analyze commensal oral yeasts in nursing home residents. Microorganisms. 2021; 9(1):142.
- Iyampillai T, Michael J, Mathai E, Mathews M. Use of CHROMagar medium in the differentiation of Candida species: is it cost-effective in developing countries?. Ann Trop Med Parasitol. 2004; 98(3):279-82.
- Bellemain E, Carlsen T, Brochmann C, Coissac E, Taberlet P, Kauserud H. ITS as an environmental DNA barcode for fungi: an in silico approach reveals potential PCR biases. BMC Microbiol. 2010; 10(1):1-9.
- Vu D, Groenewald M, Szoke S, Cardinali G, Eberhardt U, Stielow B, et al. DNA barcoding analysis of more than 9 000 yeast isolates contributes to quantitative thresholds for yeast species and genera delimitation. Stud Mycol. 2016; 85:91-105.